Finance

Lists
Why is DGX down 4.13%?
Dive Deeper
DGX:NYSE
Quest Diagnostics Inc
$234.76
-4.13%
(-10.12) 1D
$237.50
+1.17% (+2.74)
After hours
Closed: Sep 22, 4:03:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DGX...
Open
$228.59
High
$237.28
Low
$227.24
Mkt. cap
25.91B
Avg. vol.
927.96K
Volume
2.72M
Dividend
1.47%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
24.95
52-wk high
$248.84
52-wk low
$171.18
EPS
$9.41
Beta
0.55
Shares outstanding
110.37M
No. of employees
52K
Open
$228.59
High
$237.28
Low
$227.24
Mkt. cap
25.91B
Avg. vol.
927.96K
Volume
2.72M
Dividend
1.47%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
24.95
52-wk high
$248.84
52-wk low
$171.18
EPS
$9.41
Beta
0.55
Shares outstanding
110.37M
No. of employees
52K
News stories
From web sources and news partners
Profile
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
About Quest Diagnostics Inc
CEOJames E. Davis
Employees51.5K
Founded1967
Headquarters-
SectorHealth care provider
Websitequestdiagnostics.com
Analyst ratings
Based on 11 analysts giving stock ratings to DGX in the past 3 months
Buy
Buy
7
Hold
4
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for DGX in the last 3 months.
Highest
Current $234.76
$265.00 (+12.88%)
Average
$255.00 (+8.62%)
Lowest
$245.00 (+4.36%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Hold
Reiterated
$260.00
+10.8%
09/22/2026
Kevin Caliendo
UBS
Hold
Maintained
$245.00
+4.4%
09/08/2026
Erin Wright
Morgan Stanley
Buy
Maintained
$260.00
+10.8%
08/19/2026
David Toung
Argus Research
Buy
Maintained
$260.00
+10.8%
07/28/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$260.00
+10.8%
07/28/2026
Lisa Gill
J.P. Morgan
Hold
Reiterated
$250.00
+6.5%
07/28/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
$265.00
+12.9%
07/24/2026
Eric Coldwell
Robert W. Baird
Hold
Maintained
$255.00
+8.6%
07/24/2026
Luke Sergott
Barclays
Buy
Maintained
$250.00
+6.5%
07/24/2026
Tycho Peterson
Jefferies
Buy
Reiterated
$245.00
+4.4%
07/23/2026
Jared Haase
William Blair
Buy
Maintained
-
-
07/23/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
06/15/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$210.00
-10.5%
04/20/2026
Patrick B Donnelly
Citi
Hold
Maintained
$215.00
-8.4%
02/11/2026
Last report
Jul 23, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$3.12 / $2.82
+10.51%beat
Revenue / Est. (USD)
3.04B / 2.97B
+2.36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.82B
2.81B
2.90B
3.04B
Cost of goods sold
1.86B
1.89B
1.95B
2.02B
Cost of revenue
1.86B
1.89B
1.95B
2.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
491.00M
486.00M
498.00M
526.00M
Operating expense
531.00M
523.00M
533.00M
564.00M
Total operating expenses
2.40B
2.41B
2.48B
2.58B
Operating income
420.00M
392.00M
411.00M
464.00M
Other non operating income
8.00M
9.00M
-2.00M
16.00M
EBT including unusual items
336.00M
337.00M
338.00M
422.00M
EBT excluding unusual items
370.00M
344.00M
350.00M
427.00M
Income tax expense
77.00M
81.00M
74.00M
88.00M
Effective tax rate
22.92%
24.04%
21.89%
20.85%
Other operating expenses
1.00M
-
-2.00M
-
Net income
245.00M
245.00M
252.00M
320.00M
Net profit margin
8.70%
8.73%
8.70%
10.52%
Earnings per share
2.60
2.42
2.50
3.12
Interest and investment income
3.00M
3.00M
2.00M
5.00M
Interest expense
-69.00M
-67.00M
-65.00M
-68.00M
Net interest expenses
-66.00M
-64.00M
-63.00M
-63.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
562.00M
537.00M
558.00M
610.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps